Open-label phase 1 clinical trial testing personalized and targeted skull remodeling surgery to maximize TTFields intensity for recurrent glioblastoma - Interim analysis and safety assessment (OptimalTTF-1)

Anders Rosendal Korshøj, Slavka Lukacova, J. H. Sørensen, F. L. Hansen, Nikola Mikic, Axel Thielscher, Søren Ole Stigaard Cortnum, Trine Lignell Guldberg, Yasmin Lassen-Ramshad, C. Rahbek, K. E. Severinsen, Gorm Burckhard von Oettingen

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
ArtikelnummerP01.029
TidsskriftNeuro-Oncology
Vol/bind20
Udgave nummerSuppl. 3
Sider (fra-til)iii234–iii235
ISSN1522-8517
DOI
StatusUdgivet - 2018
Begivenhed13th Meeting of the European Association of Neurooncology - Stockholm, Sverige
Varighed: 10. okt. 201814. okt. 2018

Konference

Konference13th Meeting of the European Association of Neurooncology
LandSverige
ByStockholm
Periode10/10/201814/10/2018

Citationsformater